
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses
Longze Pan, Lijing Zhang, Wenjing Deng, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 133-148
Closed Access | Times Cited: 44
Longze Pan, Lijing Zhang, Wenjing Deng, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 133-148
Closed Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Multicomponent Synthesis of Imidazole-Based Ionizable Lipids for Highly Efficient and Spleen-Selective Messenger RNA Delivery
Wang Dong, Zhibin Li, Tailin Hou, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 22, pp. 15085-15095
Closed Access | Times Cited: 16
Wang Dong, Zhibin Li, Tailin Hou, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 22, pp. 15085-15095
Closed Access | Times Cited: 16
Multiarm-Assisted Design of Dendron-like Degradable Ionizable Lipids Facilitates Systemic mRNA Delivery to the Spleen
Lulu Xue, Xinhong Xiong, Gan Zhao, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 2
Lulu Xue, Xinhong Xiong, Gan Zhao, et al.
Journal of the American Chemical Society (2025)
Closed Access | Times Cited: 2
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
Hao Yang, Zhong‐Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 31
Hao Yang, Zhong‐Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 31
Bile acid-containing lipid nanoparticles enhance extrahepatic mRNA delivery
Savan K. Patel, Margaret M. Billingsley, Alvin J. Mukalel, et al.
Theranostics (2023) Vol. 14, Iss. 1, pp. 1-16
Open Access | Times Cited: 23
Savan K. Patel, Margaret M. Billingsley, Alvin J. Mukalel, et al.
Theranostics (2023) Vol. 14, Iss. 1, pp. 1-16
Open Access | Times Cited: 23
Development of mRNA Lipid Nanoparticles: Targeting and Therapeutic Aspects
Yaping Liu, Yingying Huang, Guantao He, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10166-10166
Open Access | Times Cited: 14
Yaping Liu, Yingying Huang, Guantao He, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10166-10166
Open Access | Times Cited: 14
Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery in vivo
Tian Zhang, Han Yin, Li Yu, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109804-109804
Open Access | Times Cited: 13
Tian Zhang, Han Yin, Li Yu, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109804-109804
Open Access | Times Cited: 13
Spleen-targeted delivery systems and strategies for spleen-related diseases
Ziyao Huang, Kedong Sun, Zhenyu Luo, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 773-797
Closed Access | Times Cited: 12
Ziyao Huang, Kedong Sun, Zhenyu Luo, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 773-797
Closed Access | Times Cited: 12
mRNA Vaccines Contribute to Innate and Adaptive Immunity to Enhance Immune Response In Vivo
Qiannan Cao, Huapan Fang, Huayu Tian
Biomaterials (2024) Vol. 310, pp. 122628-122628
Closed Access | Times Cited: 12
Qiannan Cao, Huapan Fang, Huayu Tian
Biomaterials (2024) Vol. 310, pp. 122628-122628
Closed Access | Times Cited: 12
Spiky metal-organic framework nanosystem for enhanced cuproptosis-mediated cancer immunotherapy
Manman Xu, Hengwen Chen, Guanghui Zhu, et al.
Nano Today (2024) Vol. 56, pp. 102231-102231
Open Access | Times Cited: 9
Manman Xu, Hengwen Chen, Guanghui Zhu, et al.
Nano Today (2024) Vol. 56, pp. 102231-102231
Open Access | Times Cited: 9
mRNA vaccine designs for optimal adjuvanticity and delivery
Yuki Mochida, Satoshi Uchida
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-27
Open Access | Times Cited: 8
Yuki Mochida, Satoshi Uchida
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-27
Open Access | Times Cited: 8
A Spleen‐Targeted Tolerogenic mRNA‐LNPs Vaccine for the Treatment of Experimental Asthma
Fazhan Wang, Jia Lou, Xiaohan Lou, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Fazhan Wang, Jia Lou, Xiaohan Lou, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Recent Advances of Emerging Spleen‐Targeting Nanovaccines for Immunotherapy
Xuanyi He, Jing Wang, Yuqing Tang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 23
Closed Access | Times Cited: 21
Xuanyi He, Jing Wang, Yuqing Tang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 23
Closed Access | Times Cited: 21
Lactobacillus plantarum modulate gut microbiota and intestinal immunity in cyclophosphamide-treated mice model
Zhibo Zeng, Zonghao Huang, Yue Wen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115812-115812
Open Access | Times Cited: 17
Zhibo Zeng, Zonghao Huang, Yue Wen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115812-115812
Open Access | Times Cited: 17
Revolutionizing medicine with toll-like receptors: A path to strengthening cellular immunity
Jonaid Ahmad Malik, Gurpreet Kaur, Javed N. Agrewala
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127252-127252
Open Access | Times Cited: 16
Jonaid Ahmad Malik, Gurpreet Kaur, Javed N. Agrewala
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127252-127252
Open Access | Times Cited: 16
Harnessing RNA Technology to Advance Therapeutic Vaccine Antigens against Chagas Disease
Chiara Mancino, Jeroen Pollet, Assaf Zinger, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 13, pp. 15832-15846
Open Access | Times Cited: 7
Chiara Mancino, Jeroen Pollet, Assaf Zinger, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 13, pp. 15832-15846
Open Access | Times Cited: 7
Steering the course of CAR T cell therapy with lipid nanoparticles
Muhammad Babar Khawar, Ali Afzal, Yue Si, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Muhammad Babar Khawar, Ali Afzal, Yue Si, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Advanced nano-based strategies for mRNA tumor vaccine
Yangqi Qu, Jingjing Xu, Tong Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 170-189
Open Access | Times Cited: 14
Yangqi Qu, Jingjing Xu, Tong Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 170-189
Open Access | Times Cited: 14
Syringeable Near-Infrared Light-Activated In Situ Immunogenic Hydrogel Boosts the Cancer-Immunity Cycle to Enhance Anticancer Immunity
Yang Fu, Xiaoxiao Zhu, Lulu Ren, et al.
ACS Nano (2024) Vol. 18, Iss. 23, pp. 14877-14892
Closed Access | Times Cited: 5
Yang Fu, Xiaoxiao Zhu, Lulu Ren, et al.
ACS Nano (2024) Vol. 18, Iss. 23, pp. 14877-14892
Closed Access | Times Cited: 5
An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity
Ling Jin, Hongwei Chen, Mengwen Huang, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113578-113578
Closed Access
Ling Jin, Hongwei Chen, Mengwen Huang, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113578-113578
Closed Access
Lipid Nanoparticles for mRNA Delivery in Cancer Immunotherapy
Yasir Alshehry, Xiang Liu, Wenhua Li, et al.
The AAPS Journal (2025) Vol. 27, Iss. 3
Closed Access
Yasir Alshehry, Xiang Liu, Wenhua Li, et al.
The AAPS Journal (2025) Vol. 27, Iss. 3
Closed Access
Cancer Nanovaccines: Mechanisms, Design Principles, and Clinical Translation
Gabriel de Camargo Zaccariotto, Maria Julia Bistaffa, Angelica Maria Mazuera Zapata, et al.
ACS Nano (2025)
Open Access
Gabriel de Camargo Zaccariotto, Maria Julia Bistaffa, Angelica Maria Mazuera Zapata, et al.
ACS Nano (2025)
Open Access
Discovery of Ketal‐Ester Ionizable Lipid Nanoparticle with Reduced Hepatotoxicity, Enhanced Spleen Tropism for mRNA Vaccine Delivery
Kai Lv, Zhenlei Yu, Jing Wang, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
Kai Lv, Zhenlei Yu, Jing Wang, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity
Ting Fan, Congcong Xu, J. Wu, et al.
Science Advances (2024) Vol. 10, Iss. 41
Open Access | Times Cited: 4
Ting Fan, Congcong Xu, J. Wu, et al.
Science Advances (2024) Vol. 10, Iss. 41
Open Access | Times Cited: 4
Tolerogenic nanovaccines for the treatment of type I allergic diseases
Yueping Ren, Daoke Yao, Fang Wu, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 664-685
Closed Access
Yueping Ren, Daoke Yao, Fang Wu, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 664-685
Closed Access
Developing mRNA Nanomedicines with Advanced Targeting Functions
Ji Wang, Lijun Cai, Ning Li, et al.
Nano-Micro Letters (2025) Vol. 17, Iss. 1
Open Access
Ji Wang, Lijun Cai, Ning Li, et al.
Nano-Micro Letters (2025) Vol. 17, Iss. 1
Open Access